Author:
Sivalingam Azhagu Madhavan,Pandian Arjun
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky BJNRC. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024:21:617–31.
2. Gholamalizadeh H, Ensan B, Sukhorukov VN, Sahebkar AJJOP. Pharmacology. Targeting the CCL2–CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases. J Pharm Pharm. 2024;76:138–53.
3. Lin Y, Lin R, Lin H-B, Shen SJMIDD. Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis. Med Drug Discov. 2024;22:100189.
4. Mitsis A, Kyriakou M, Sokratous S, Karmioti G, Drakomathioulakis M, Myrianthefs M, et al. Exploring the landscape of anti-inflammatory trials: a comprehensive review of strategies for targeting inflammation in acute myocardial infraction. Biomed. 2024;12:701.
5. Moras E, Subramanian L, Romeo F, Gandhi K, Prabhakaran SY, Moras A, et al. Role of colchicine in cardiovascular disorders. Cardiol Rev. 2024;10:1097.